Completed
Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-
NCT00622830
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +2 more
- Locations
-
- GSK Investigational Site Ibaraki, Japan